Neurologic manifestations of the antiphospholipid syndrome.
Neurologic disorders are among the most prominent clinical manifestations associated with the antiphospholipid syndrome. Such neurologic disorders are predominantly related to focal central nervous system thrombo-occlusive events. This review summarizes the latest data regarding the clinical aspects of stroke and other neurologic manifestations associated with antiphospholipid antibodies.
Tanne
D
D
Acute Stroke Unit and Department of Neurology, Chaim Sheba Medical Center, Tel Hashomer, 52621, Israel. tanne@post.tau.ac.il
Hassin-Baer
S
S
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000175:diagnosis / Q000209:etiology; D017152:Antibodies, Antiphospholipid / Q000032:analysis*; D016736:Antiphospholipid Syndrome / Q000150:complications / Q000175:diagnosis*; D002545:Brain Ischemia / Q000175:diagnosis / Q000209:etiology / Q000276:immunology; D002493:Central Nervous System Diseases / Q000175:diagnosis / Q000209:etiology* / Q000276:immunology; D002561:Cerebrovascular Disorders / Q000175:diagnosis / Q000209:etiology / Q000276:immunology; D002648:Child; D002819:Chorea / Q000175:diagnosis / Q000209:etiology / Q000276:immunology; D003704:Dementia / Q000175:diagnosis / Q000209:etiology / Q000276:immunology; D005260:Female; D020275:Guillain-Barre Syndrome / Q000175:diagnosis / Q000209:etiology / Q000276:immunology; D006801:Humans; D020767:Intracranial Thrombosis / Q000175:diagnosis / Q000209:etiology / Q000276:immunology; D002546:Ischemic Attack, Transient / Q000175:diagnosis / Q000209:etiology / Q000276:immunology; D008297:Male; D008875:Middle Aged; D008881:Migraine Disorders / Q000175:diagnosis / Q000209:etiology / Q000276:immunology; D009103:Multiple Sclerosis / Q000175:diagnosis / Q000209:etiology / Q000276:immunology; D012307:Risk Factors
D017152:Antibodies, Antiphospholipid